What is the primary objective of FDA 21 CFR Part 11?

The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the FDA considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper (§11.1(a)). This equivalency enables electronic methods while ensuring authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), access limitations (§11.10(d)), and signature linking (§11.70).

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or submitted electronically to FDA (§11.1(b)). This includes pharmaceutical, biotech, medical device, and CRO/CMO firms relying on electronic records in lieu of paper for regulated activities, or where electronic versions are relied upon even if paper exists; exclusions apply to certain food records (§11.1(f)–(p)) and paper records transmitted electronically.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal controls, validation (§11.10(a)), SOPs, training (§11.10(i)), and inspection readiness (§11.1(e)), with systems and documentation readily available for FDA review; the 2003 guidance emphasizes risk-based approaches without mandating external validation.

How often should an assessment for FDA 21 CFR Part 11 be performed?

FDA 21 CFR Part 11 does not specify a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based revalidation to maintain system fitness (§11.10(k)). Ongoing monitoring includes audit trail reviews, access checks, and retraining, integrated into quality systems with reassessments triggered by changes, inspections, or predicate rule updates per 2003 guidance.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 can result in FDA enforcement actions including Form 483 observations, warning letters, product holds, and predicate rule violations leading to fines or injunctions. The 2003 guidance notes continued enforcement of access controls (§11.10(d)), signatures (§§11.50–11.300), and predicate rules, with data integrity failures often cited in inspections (e.g., inadequate audit trails or signatures).

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

Yes, FDA 21 CFR Part 11 controls such as audit trails, access limitations, and electronic signatures can align with frameworks like EU Annex 11 via risk-based approaches emphasizing data integrity (ALCOA+). Common mappings include closed/open system controls (§§11.10, 11.30) to Annex 11 validation and encryption, though Part 11 remains distinct in scope and enforcement discretion.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and documenting reliance on electronic vs. paper versions (per 2003 guidance). This risk-based scoping identifies Part 11 records, classifies systems as closed/open (§11.3(b)(4),(9)), and prioritizes controls like access and signatures.

What is the primary objective of ISO 14064?

ISO 14064 provides requirements and guidance for quantifying, reporting, and verifying greenhouse gas (GHG) emissions and removals. The standard family—ISO 14064-1:2018 for organizational inventories, ISO 14064-2:2019 for project-level reductions/removals, and ISO 14064-3:2019 for validation/verification—ensures inventories adhere to five principles: relevance, completeness, consistency, transparency, and accuracy. It enables credible GHG statements for regulatory reporting, investor disclosure, and carbon markets.

Who is legally or professionally required to comply with ISO 14064?

No organization is legally mandated to comply with ISO 14064, as it is a voluntary international standard. It is professionally required for entities preparing credible GHG inventories, including companies, governments, NGOs, project developers, and verification bodies facing stakeholder demands for verifiable data. Users include those in emissions trading, green finance, or supply-chain reporting, where ISO 14064 demonstrates methodological rigor.

Does ISO 14064 require an external audit or third-party certification?

ISO 14064 does not require external audit or third-party certification. Parts 1 and 2 provide self-implementation guidance, while ISO 14064-3 outlines optional validation/verification processes (limited or reasonable assurance). Third-party assurance, often by ISO 14065-compliant bodies, enhances credibility for markets but remains voluntary.

How often should an assessment for ISO 14064 be performed?

ISO 14064 assessments should be performed annually to ensure consistency and comparability. Organizational inventories under ISO 14064-1 cover a defined reporting period (typically calendar year), with base-year recalculations for significant structural changes. Project monitoring under ISO 14064-2 follows the defined plan, and verification under ISO 14064-3 aligns with reporting cycles or stakeholder needs.

What are the consequences of non-compliance with ISO 14064?

Non-compliance with ISO 14064 carries no direct penalties, as it is voluntary. Indirect consequences include rejected GHG claims, exclusion from carbon markets or green finance, regulatory scrutiny under disclosure regimes, and reputational damage from unverifiable assertions. Weak inventories fail ISO 14064-3 assurance, eroding stakeholder trust.

Can ISO 14064 be mapped to other international frameworks?

Yes, ISO 14064 aligns closely with the GHG Protocol Corporate Standard's principles and scope classifications. Its five principles (relevance, completeness, consistency, transparency, accuracy) mirror GHG Protocol requirements, enabling interoperable inventories for Scopes 1-3. It supports integration with environmental management systems like ISO 14001 via PDCA cycles.

What is the first step to begin implementing ISO 14064?

The first step is defining organizational and operational boundaries. Select consolidation approach (equity share or control—operational/financial), identify emission sources/sinks across direct and indirect categories, and document relevance to decision-making needs, per ISO 14064-1 requirements.

Standards Comparison

FDA 21 CFR Part 11 vs ISO 14064

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for electronic records and signatures equivalency

ISO 14064

Voluntary

2018

International standard for GHG quantification, reporting, verification

Quick Verdict

FDA 21 CFR Part 11 mandates electronic record integrity for life sciences compliance, while ISO 14064 provides voluntary GHG accounting frameworks for all sectors. Pharma adopts Part 11 to avoid FDA enforcement; others use ISO 14064 for credible sustainability reporting and verification.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

12-18 months

Key Features

Establishes equivalency for electronic records and signatures
Mandates secure time-stamped audit trails for changes
Requires unique linked electronic signatures non-repudiation
Differentiates controls for closed versus open systems
Enforces risk-based validation and access controls

Greenhouse Gas Accounting

ISO 14064

ISO 14064: Greenhouse gases specification with guidance

Cost

€€€

Complexity

High

Implementation Time

6-12 months

Key Features

Three-part framework for inventories, projects, verification
Five principles: relevance, completeness, consistency, transparency, accuracy
Direct and indirect (Categories 1-6) emission boundary classification
Risk-based validation and assurance processes
Alignment with GHG Protocol methodologies

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated industries using computerized systems for predicate rule records like batch records or submissions. Employs a risk-based approach with narrow scope via 2003 guidance, emphasizing reliance on electronic records.

Key Components

**Subpart AScope, implementation, definitions (closed/open systems).
**Subpart BClosed system controls (§11.10: validation, audit trails, access); open systems (§11.30: encryption, digital signatures); signature linking (§11.70).
**Subpart CUnique signatures (§11.100), multi-component controls (§11.200), ID/password security (§11.300). Built on authenticity, integrity, non-repudiation; no formal certification—compliance demonstrated via inspection.

Why Organizations Use It

Mandatory for regulated firms to avoid warnings, holds; ensures data integrity for decisions, investigations. Benefits: efficiency, inspection readiness, quality improvement, stakeholder trust. Reduces risks from poor records.

Implementation Overview

Phased risk-based: scope predicate records, classify systems, CSV (URS, IQ/OQ/PQ), deploy controls (audit trails, signatures, training), SOPs, vendor governance. Suits pharma/devices/biotech globally; ongoing change control, audits. (178 words)

ISO 14064 Details

What It Is

ISO 14064 is the international standard family (ISO 14064-1:2018, ISO 14064-2:2019, ISO 14064-3:2019) specifying requirements for GHG emissions and removals quantification, reporting, and assurance. It provides a modular, principle-based framework: Part 1 for organizational inventories, Part 2 for project-level reductions, and Part 3 for validation/verification. Core approach emphasizes relevance, completeness, consistency, transparency, accuracy.

Key Components

**Part 1Boundary setting, direct and indirect emissions (Categories 1-6), data quality management.
**Part 2Baselines, additionality, monitoring for projects.
**Part 3Risk-based assurance, materiality, evidence gathering. Built on five principles aligned with GHG Protocol; compliance via third-party verification (ISO 14065).

Why Organizations Use It

Supports regulatory compliance (CSRD, SB-253), investor disclosures, carbon markets. Enhances credibility, reduces greenwashing risks, drives decarbonization, builds stakeholder trust.

Implementation Overview

Phased: governance, boundaries, data collection, reporting, verification. Applies to all sizes/industries globally; 6-12 months typical, with optional assurance.

Key Differences

Aspect	FDA 21 CFR Part 11	ISO 14064
Scope	Electronic records/signatures trustworthiness	GHG emissions inventories, projects, verification
Industry	Life sciences, pharma, medical devices	All sectors worldwide, environmental reporting
Nature	Mandatory US FDA regulation	Voluntary international standard
Testing	System validation, audit trails, FDA inspection	Independent GHG verification, reasonable/limited assurance
Penalties	Warning letters, product holds, fines	No legal penalties, loss of credibility

Scope

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness

ISO 14064

GHG emissions inventories, projects, verification

Industry

FDA 21 CFR Part 11

Life sciences, pharma, medical devices

ISO 14064

All sectors worldwide, environmental reporting

Nature

FDA 21 CFR Part 11

Mandatory US FDA regulation

ISO 14064

Voluntary international standard

Testing

FDA 21 CFR Part 11

System validation, audit trails, FDA inspection

ISO 14064

Independent GHG verification, reasonable/limited assurance

Penalties

FDA 21 CFR Part 11

Warning letters, product holds, fines

ISO 14064

No legal penalties, loss of credibility

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and ISO 14064

FDA 21 CFR Part 11 FAQ

ISO 14064 FAQ

You Might also be Interested in These Articles...

Top 10 Reasons CMMC Level 3 Certification Unlocks Competitive Edge for Primes Handling Critical DoD Programs

Discover top 10 reasons CMMC Level 3 certification unlocks competitive edge for DoD primes. Reduced APT risks, procurement prefs, NIST 800-172 compliance via v2

NIST CSF 2.0 Deep Dive: Mastering the Updated Framework Core Functions

Unpack NIST CSF 2.0's enhanced Core Functions: Govern, Identify, Protect, Detect, Respond, Recover. Get SME playbooks, governance shifts & strategies for cyber

Singapore PDPA Implementation Guide: Mastering Part 6A Breach Notification Thresholds and Timelines from Primary Statute

Master Singapore PDPA Part 6A breach notifications: statutory thresholds (risk of significant harm), 72-hour timelines, checklists, templates & frameworks. Comp

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how FDA 21 CFR Part 11 and ISO 14064 compare against other standards

Other FDA 21 CFR Part 11 Comparisons

Other ISO 14064 Comparisons

What It Is

Key Components

**Subpart AScope, implementation, definitions (closed/open systems).

**Subpart BClosed system controls (§11.10: validation, audit trails, access); open systems (§11.30: encryption, digital signatures); signature linking (§11.70).

**Subpart CUnique signatures (§11.100), multi-component controls (§11.200), ID/password security (§11.300). Built on authenticity, integrity, non-repudiation; no formal certification—compliance demonstrated via inspection.

What It Is

Key Components

**Part 1Boundary setting, direct and indirect emissions (Categories 1-6), data quality management.

**Part 2Baselines, additionality, monitoring for projects.

**Part 3Risk-based assurance, materiality, evidence gathering. Built on five principles aligned with GHG Protocol; compliance via third-party verification (ISO 14065).

Aspect

FDA 21 CFR Part 11

ISO 14064

Scope

Electronic records/signatures trustworthiness

GHG emissions inventories, projects, verification

Industry

Life sciences, pharma, medical devices

All sectors worldwide, environmental reporting

Nature

Mandatory US FDA regulation

Voluntary international standard

Testing

System validation, audit trails, FDA inspection

Independent GHG verification, reasonable/limited assurance

Penalties

Warning letters, product holds, fines

No legal penalties, loss of credibility